[Silymarin action in liver diseases].
D000410:Alanine Transaminase / Q000097:blood; D000438:Alcohols / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001654:Bile Pigments / Q000652:urine; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001772:Blood Cell Count; D001798:Blood Proteins / Q000032:analysis; D001799:Blood Sedimentation; D002463:Cell Membrane Permeability / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D004035:Diet Therapy; D005419:Flavonoids / Q000627:therapeutic use*; D005951:Glucose Tolerance Test; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007501:Iron / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy* / Q000201:enzymology; D008111:Liver Function Tests; D010936:Plant Extracts / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000438:Alcohols; D001654:Bile Pigments; D001798:Blood Proteins; D005419:Flavonoids; D010936:Plant Extracts; D014280:Triglycerides; D002784:Cholesterol; D007501:Iron; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Uber die Objektivierung der Silymarinwirkung bei Lebererkrankungen.